Immix Biopharma (IMMX) Stock Forecast for 2024–2028. Sell or Buy Prediction







6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …
Trading Penny Stocks for Profit: Expert Insights and Practical Advice

February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice

For aspiring traders and seasoned investors alike, the enticing appeal of penny stocks can be likened to voyaging across the vast oceans, discovering…
Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

February 15, 2024 Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

At historically low interest rates, refinancing can seem tempting; but applications for refinance could be denied for various reasons. Underwriters need assurances that…

Immix Biopharma (IMMX) Stock Forecast for 2024–2028. Sell or Buy?

Updated: March 29, 2024 (07:08)

Sector: Healthcare

The share price of Immix Biopharma, Inc. (IMMX) now

Latest session on the 28th of March for
Immix Biopharma, Inc. is negative
Trading Volume: 94564
Open: 3.04 /  High: 3.23 /  Low: 3
What analysts predict: $14
52-week High/Low: $7.75 / $1.4

50/200 Day Moving Average: $3.602 / $3.482

This figure corresponds to the Average Price over the previous 50/200 days. For Immix Biopharma stocks, the 50-day moving average is the resistance level today.

For Immix Biopharma stocks, the 200-day moving average is the resistance level today.

Are you interested in Immix Biopharma, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Immix Biopharma stock price in 2024, 2025, 2026, 2027, 2028. How much will one Immix Biopharma share be worth in 2024 - 2028?

When should I take profit in Immix Biopharma stock? When should I record a loss on Immix Biopharma stock? What are analysts' forecasts for Immix Biopharma stock? What is the future of Immix Biopharma stock? We forecast Immix Biopharma stock performance using neural networks based on historical data on Immix Biopharma stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Immix Biopharma stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Immix Biopharma shares. This happens once a day.


Historical and forecast chart of Immix Biopharma stock

The chart below shows the historical price of Immix Biopharma stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Immix Biopharma stock price can be found in the table below.

Long-term forecasts by years.

Immix Biopharma is a United States-based clinical stage biopharmaceutical company with a division in Australia (Immix Biopharma Australia).
Immix Biopharma conducts research in the treatment of cancer and inflammatory diseases. The company’s key experimental line, IMX-110, is in phase 1b / 2a clinical trials and is being investigated for efficacy in the treatment of solid tumors. Tests are taking place in the United States and Australia.

Immix Biopharma daily forecast for a month

Date Target Pes. Opt. Vol., %
Mar 31 3.21 3.14 3.34 6.37
Apr 01 3.27 3.18 3.41 7.10
Apr 02 3.34 3.23 3.41 5.53
Apr 03 3.33 3.29 3.44 4.55
Apr 04 3.26 3.12 3.35 7.20
Apr 05 3.41 3.34 3.47 4.11
Apr 06 3.33 3.28 3.37 2.74
Apr 07 3.38 3.27 3.54 8.38
Apr 08 3.53 3.46 3.67 6.19
Apr 09 3.50 3.40 3.63 6.73
Apr 10 3.47 3.40 3.61 6.17
Apr 11 3.54 3.41 3.63 6.40
Apr 12 3.60 3.47 3.69 6.09
Apr 13 3.57 3.48 3.62 4.12
Apr 14 3.52 3.42 3.69 7.97
Apr 15 3.62 3.49 3.67 5.17
Apr 16 3.65 3.57 3.81 6.93
Apr 17 3.56 3.43 3.65 6.35
Apr 18 3.38 3.33 3.45 3.65
Apr 19 3.38 3.31 3.43 3.61
Apr 20 3.33 3.22 3.37 4.65
Apr 21 3.34 3.22 3.39 5.36
Apr 22 3.49 3.44 3.57 3.83
Apr 23 3.69 3.62 3.83 5.93
Apr 24 3.86 3.69 4.04 9.75
Apr 25 3.80 3.67 3.92 6.96
Apr 26 3.69 3.58 3.76 5.00
Apr 27 3.67 3.54 3.83 8.14
Apr 28 3.55 3.47 3.67 5.97
Apr 29 3.65 3.58 3.79 5.82

Immix Biopharma Daily Price Targets


Immix Biopharma Stock Forecast 03-31-2024.

Forecast target price for 03-31-2024: $3.21.
Positive dynamics for Immix Biopharma shares will prevail with possible volatility of 5.992%.
Pessimistic target level: 3.14
Optimistic target level: 3.34

Immix Biopharma Stock Forecast 04-01-2024.

Forecast target price for 04-01-2024: $3.27.
Positive dynamics for Immix Biopharma shares will prevail with possible volatility of 6.626%.
Pessimistic target level: 3.18
Optimistic target level: 3.41

Immix Biopharma Stock Forecast 04-02-2024.

Forecast target price for 04-02-2024: $3.34.
Positive dynamics for Immix Biopharma shares will prevail with possible volatility of 5.242%.
Pessimistic target level: 3.23
Optimistic target level: 3.41

Immix Biopharma Stock Forecast 04-03-2024.

Forecast target price for 04-03-2024: $3.33.
Negative dynamics for Immix Biopharma shares will prevail with possible volatility of 4.356%.
Pessimistic target level: 3.29
Optimistic target level: 3.44

Immix Biopharma Stock Forecast 04-04-2024.

Forecast target price for 04-04-2024: $3.26.
Negative dynamics for Immix Biopharma shares will prevail with possible volatility of 6.715%.
Pessimistic target level: 3.12
Optimistic target level: 3.35

Immix Biopharma Stock Forecast 04-05-2024.

Forecast target price for 04-05-2024: $3.41.
Positive dynamics for Immix Biopharma shares will prevail with possible volatility of 3.949%.
Pessimistic target level: 3.34
Optimistic target level: 3.47

IMMX (IMMX) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Apr. 2.93 2.53 3.40 25.67
May. 3.21 2.71 3.40 20.19
Jun. 3.00 2.59 3.50 25.80
Jul. 2.52 2.12 2.85 25.64
Aug. 2.15 2.05 2.36 13.19
Sep. 1.92 1.73 2.22 22.32
Oct. 1.91 1.60 2.20 27.18
Nov. 1.96 1.63 2.04 20.31
Dec. 1.98 1.88 2.22 15.22

Immix Biopharma forecast for this year


Immix Biopharma Stock Prediction for Apr 2024

An downtrend is forecast for this month with an optimal target price of $2.92874. Pessimistic: $2.53. Optimistic: $3.40


Immix Biopharma Stock Prediction for May 2024

An uptrend is forecast for this month with an optimal target price of $3.2055. Pessimistic: $2.71. Optimistic: $3.40


Immix Biopharma Stock Prediction for Jun 2024

An downtrend is forecast for this month with an optimal target price of $3.00356. Pessimistic: $2.59. Optimistic: $3.50


Immix Biopharma Stock Prediction for Jul 2024

An downtrend is forecast for this month with an optimal target price of $2.51788. Pessimistic: $2.12. Optimistic: $2.85


Immix Biopharma Stock Prediction for Aug 2024

An downtrend is forecast for this month with an optimal target price of $2.14775. Pessimistic: $2.05. Optimistic: $2.36


Immix Biopharma Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $1.92224. Pessimistic: $1.73. Optimistic: $2.22


Immix Biopharma Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $1.91417. Pessimistic: $1.60. Optimistic: $2.20


Immix Biopharma Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $1.95838. Pessimistic: $1.63. Optimistic: $2.04


Immix Biopharma Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $1.98306. Pessimistic: $1.88. Optimistic: $2.22



Immix Biopharma (IMMX) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 1.86 1.57 2.02 22.19
Feb 1.85 1.62 2.11 23.52
Mar 1.91 1.59 2.21 28.25
Apr 1.71 1.60 1.82 12.40
May 1.55 1.36 1.66 18.07
Jun 1.55 1.32 1.77 25.36
Jul 1.75 1.51 1.90 20.50
Aug 1.97 1.76 2.14 17.95
Sep 2.09 1.78 2.34 23.91
Oct 2.17 2.07 2.35 11.82
Nov 2.02 1.70 2.32 26.86
Dec 1.99 1.82 2.12 14.36

Immix Biopharma (IMMX) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 2.03 1.69 2.20 22.95
Feb 2.15 1.87 2.30 18.66
Mar 2.03 1.93 2.20 12.59
Apr 2.06 1.82 2.25 19.42
May 2.18 1.97 2.30 14.34
Jun 2.20 2.03 2.46 17.29
Jul 1.97 1.83 2.17 15.80
Aug 1.78 1.59 2.00 20.18
Sep 1.66 1.39 1.77 21.84
Oct 1.75 1.48 2.04 27.74
Nov 1.84 1.65 2.01 17.72
Dec 2.13 1.97 2.47 20.43

Immix Biopharma (IMMX) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 2.16 1.84 2.36 22.06
Feb 2.59 2.43 2.74 11.33
Mar 2.71 2.39 3.11 23.25
Apr 3.23 2.89 3.62 20.37
May 3.49 3.05 3.95 22.81
Jun 4.07 3.86 4.24 8.87
Jul 4.38 4.08 4.91 16.85
Aug 4.03 3.78 4.46 15.17
Sep 4.10 3.66 4.53 19.19
Oct 3.96 3.68 4.62 20.35
Nov 3.91 3.56 4.21 15.42
Dec 4.09 3.47 4.35 20.31

Immix Biopharma (IMMX) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 3.81 3.17 4.34 26.93
Feb 4.47 3.76 5.00 24.94
Mar 4.29 3.69 4.81 23.40
Apr 4.68 4.09 5.15 20.60
May 5.30 4.62 5.60 17.49
Jun 5.23 4.87 6.03 19.30
Jul 4.58 4.03 5.19 22.26
Aug 5.00 4.24 5.32 20.31
Sep 4.04 3.78 4.62 18.19
Oct 4.02 3.62 4.53 20.10
Nov 3.62 3.32 3.94 15.82
Dec 4.23 4.05 4.57 11.28

Immix Biopharma information and performance

Immix Biopharma Address

11400 WEST OLYMPIC BLVD., SUITE 200, LOS ANGELES, CA, US

Market Capitalization: 84 010 000 $

Market capitalization of the Immix Biopharma, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of IMMX shares in the company outstanding by the market price of one share.

EBITDA: -14 556 881 $

EBITDA of Immix Biopharma is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.92

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: -4.573

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 25534900

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.